Current discharge management of acute coronary syndromes: Data from the Rijnmond Collective Cardiology Research (CCR) study

Netherlands Heart Journal

Volumn 22, Issue 1, 2014, Pages 20-27

  Yetgin, T ^a   van der Linden, M M J M ^a,b   de Vries, A G ^c   Smits, P C ^d   van Mechelen, R ^e   Yap, S C ^a   Boersma, E ^a   Zijlstra, F ^a   van Geuns, R J M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Vlietland Hospital   (Netherlands)

^c ALBERT SCHWEITZER HOSPITAL   (Netherlands)

^d Maasstad Hospital ^*  (Netherlands)

^e SINT FRANCISCUS GASTHUIS   (Netherlands)

Author keywords

Acute coronary syndrome; Percutaneous coronary intervention; Post discharge medication

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; THIENOPYRIDINE DERIVATIVE;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; FEMALE; FOLLOW UP; HOSPITAL DISCHARGE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; UNSTABLE ANGINA PECTORIS;

EID: 84892564699     PISSN: 15685888     EISSN: 18766250     Source Type: Journal    
DOI: 10.1007/s12471-013-0484-x     Document Type: Article

References (22)

1. Eagle KA, Montoye CK, Riba AL, et al. Guideline-based standardized care is associated with substantially lower mortality in medicare patients with acute myocardial infarction: the American College of Cardiology's Guidelines Applied in Practice (GAP) Projects in Michigan. J Am Coll Cardiol. 2005;46(7):1242-8.
2. Melloni C, Newby LK. Risk factor management after acute coronary syndromes. Heart. 2009;95(17):1382-4.
3. Hamm CW, Bassand JP, Agewall S, et al. ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the task force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2011;32(23):2999-3054.
4. Wijns W, Kolh P, Danchin N, et al. Guidelines on myocardial revascularization. Eur Heart J. 2010;31(20):2501-55.
5. Steg PG, James SK, Atar D, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with STsegment elevation. Eur Heart J. 2012;33(20):2569-619.
6. Wright RS, Anderson JL, Adams CD, et al. 2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American Academy of Family Physicians, Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons. J Am Coll Cardiol. 2011;57(19):e215-367.
7. Krumholz HM, Anderson JL, Bachelder BL, et al. ACC/AHA 2008 performance measures for adults with ST-elevation and non-STelevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to develop performance measures for ST-elevation and non-ST-elevationmyocardial infarction): developed in collaborationwith theAmericanAcademy of Family Physicians and the American College of Emergency Physicians: endorsed by theAmerican Association of Cardiovascular and Pulmonary Rehabilitation, Society for Cardiovascular Angiography and Interventions, and Society of Hospital Medicine. Circulation. 2008;118(24):2596-648.
8. Brilakis ES, Hernandez AF, Dai D, et al. Quality of care for acute coronary syndrome patients with known atherosclerotic disease: results from the Get With the Guidelines Program. Circulation. 2009;120(7):560-7.
9. Yetgin T, van der Linden MMJM, Vries AG, et al. Adoption of prasugrel into routine practice: rationale and design for the Rijnmond Collective Cardiology Research (CCR) study in percutaneous coronary intervention for acute coronary syndromes. Neth Heart J. 2013;21. doi:10.1007/s12471-013-0472-1.
10. Shah BR, Drozda J, Peterson ED. Leveraging observational registries to inform comparative effectiveness research. Am Heart J. 2010;160(1):8-15.
11. Granger CB, Steg PG, Peterson E, et al. Medication performance measures and mortality following acute coronary syndromes. Am J Med. 2005;118(8):858-65.
12. Roe MT, Peterson ED, Newby LK, et al. The influence of risk status on guideline adherence for patients with non-ST-segment elevation acute coronary syndromes. Am Heart J. 2006;151(6):1205-13.
13. Cheng CI, Chen CP, Kuan PL, et al. The causes and outcomes of inadequate implementation of existing guidelines for antiplatelet treatment in patients with acute coronary syndrome: the experience from Taiwan Acute Coronary Syndrome Descriptive Registry (T-ACCORD Registry). Clin Cardiol. 2010;33(6):E40-8.
14. Javed U, Deedwania PC, Bhatt DL, et al. Use of intensive lipidlowering therapy in patients hospitalized with acute coronary syndrome: an analysis of 65,396 hospitalizations from 344 hospitals participating in Get With The Guidelines (GWTG). Am Heart J. 2010;160(6):1130-6. 6 e1-3.
15. Bramlage P, Messer C, Bitterlich N, et al. The effect of optimal medical therapy on 1-year mortality after acutemyocardial infarction. Heart. 2010;96(8):604-9.
16. Salomaa V, Paakkonen R, Hamalainen H, et al. Use of secondary preventive medications after the first attack of acute coronary syndrome. Eur J Cardiovasc Prev Rehabil. 2007;14(3):386-91.
17. Bi Y, Gao R, Patel A, et al. Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study. Am Heart J. 2009;157(3):509-16 e1.
18. Lee JH, Yang DH, Park HS, et al. Suboptimal use of evidencebased medical therapy in patients with acute myocardial infarction from the Korea Acute Myocardial Infarction Registry: prescription rate, predictors, and prognostic value. Am Heart J. 2010;159(6): 1012-9.
19. Atary JZ, de Visser M, van den Dijk R, et al. Standardised prehospital care of acute myocardial infarction patients: MISSION! guidelines applied in practice. Neth Heart J. 2010;18(9):408-15.
20. Six AJ, Backus BE, Kingma A, et al. Consumption of diagnostic procedures and other cardiology care in chest pain patients after presentation at the emergency department. Neth Heart J. 2012;20(12): 499-504.
21. Gislason GH, Rasmussen JN, Abildstrom SZ, et al. Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction. Eur Heart J. 2006;27(10):1153-8.
22. Lee HY, Cooke CE, Robertson TA. Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge. J Manag Care Pharm. 2008;14(3):271-80.